All posts by Amity Westcott-Chavez

Paisley’s Journey with Eosinophilic Esophagitis (EoE)

In honor of National Eosinophil Awareness Week, we’re resharing Paisley’s journey with eosinophilic esophagitis (EoE), from diagnosis to treatment. It’s a powerful patient story of raising EoE awareness from our 2023 newsletter archives. We thank Ali Platt for sharing her daughter Paisley’s story with APFED and for providing an update on Paisley’s journey with EoE today.

In March 2019, Paisley Kaye was born. As first-time parents, we couldn’t have been more elated. Her first year of life was somewhat normal. Any concerns we had were dismissed as “normal baby things.”

As time went on, symptoms evolved as a series of odd events. For example, Paisley was a pacifier lover. One day in January, she suddenly could not put it in her mouth without violently gagging. Her beloved cup of cow’s milk now caused severe flushing on her cheeks.

I was constantly sending messages to her primary care physician accompanied by photographs. Paisley was referred to countless specialists. When she had her initial visit with gastroenterology, I was skeptical that there was a good reason for them to evaluate her. I was stunned when the doctor wanted to perform an endoscopy. Was it really necessary? Were there less invasive things we could do first? Nevertheless, I scheduled the procedure and tearfully watched as they wheeled her away.

After the procedure, the doctor told me her esophagus visually looked good. However, we had to wait one week to learn biopsy results. I’ll never forget the day I got them. The doctor said, “I have an answer, and I also have a solution.” The answer was eosinophilic esophagitis, and he went on to say the solution was strict food elimination or a combination of a steroid and acid reducer.

Food elimination never seemed like an option for Paisley. Her diet was already so limited. We had been so excited to introduce baby foods to her and she hated them – all of them. This made so much sense in retrospect. After weighing options, we proceeded with medications. I gave it time for the medications to work, and I followed up with the remaining specialists we were referred to. Unfortunately, Paisley was still struggling, and even worse, the doctor could not offer any help beyond the initial solution.

Paisley was choking, pocketing food, vomiting in her sleep, developing rashes, and just overall uncomfortable. These symptoms would present daily. We got a second opinion from another gastroenterologist, who changed her medication regimen. Though it put her EoE into remission, her symptoms did not resolve.

We made the decision to travel out-of-state to a third gastroenterologist. It was this doctor who completely changed Paisley’s life. Simple, yet profound, he asked, “What if EoE isn’t the root of all of these symptoms?” While he didn’t have all the answers, he did his due diligence in finding a team who did. This meant more referrals, more specialists, more appointments, more lab work, more tests, and more procedures.

Since that day, Paisley’s journey has been long and plagued with ups and downs. She was diagnosed with reactive airway disease and environmental allergies, folliculitis, Loose Anagen Syndrome, connective tissue disease and tracheomalacia, and had adenoids obstructing her airway, which she has since had removed.

Finally, we had answers to persistent symptoms. Though we [her parents and medical team] aren’t convinced we’ve identified all the pieces to the puzzle, we are happy with the progress and the improvements to Paisley’s daily comfort and quality of life.

What’s Next for Paisley

I am pleased to say she was approved for biologic medication, which she started early July. Our goal is to wean her off steroids in the hope that her adrenal function returns to normal and eliminates her adrenal insufficiency diagnosis altogether. We’re also incredibly hopeful this will improve her esophageal tissue. Despite her eosinophil counts staying low, her endoscopies repeatedly show inflammation and damage. We’re also hoping other symptoms resolve, including her asthma-like troubles and skin manifestations

Paisley Prompts Wisconsin to Recognize Awareness Week

I felt compelled to do my part to advocate for the EoE community as a whole. Each year, APFED celebrates National Eosinophil Awareness Week, in which landmarks light up. I was unsuccessful in getting local landmarks to light up, due to their lighting capabilities. However, the representative for the Wisconsin Capitol Building suggested I submit information for a Proclamation in honor of National Eosinophil Awareness Week. I did just that, and it was approved!

While we couldn’t “light up” the Capitol building purple, we put our own spin on it by dressing head to toe in purple. When we arrived at the Capitol Building, Paisley found the clicking of her heels to be hilarious. She stood in front of the building, and we read the Proclamation together. We discussed how far she had come with her treatment and how many others she could help by sharing her story. Those passing by stopped to comment on her “cuteness,” which we used as an opportunity to educate and spread awareness. The highlight of the day was seeing Paisley so proud of herself.

Spreading Awareness in Your Community

I don’t believe there is any one way to spread awareness in your community. The best thing you can do is understand your strengths and run with them. Further, identify things your child enjoys so that spreading awareness is fun. I have a passion for photography, storytelling, and social media. Paisley is an entertainer, who loves making her own vlogs. We paired this together and began sharing her story on TikTok (@PaisleySays). This educates anyone who watches and connects us with others who share the diagnosis.

Another way to bring awareness is by starting a conversation. A single conversation can lead to so much more, as it has for us. Paisley and I challenge you to start conversations — don’t be afraid to tell your story!

May 2025 Update from Ali Platt

Since sharing our story, we’ve continued working to uncover the full picture of Paisley’s health. We’ve identified more pieces of her medical puzzle, but it remains an ongoing journey. Paisley continues to receive injections of her biologic medication to manage her EoE. While it has helped in several ways, an endoscopy in March 2025 revealed active disease.

We’re now fine-tuning her treatment regimen in hopes of minimizing symptoms of food impaction, dysphagia, and vomiting. Despite the setback, we remain hopeful. Each discovery, each adjustment, brings us closer to understanding her needs and giving her the quality of life she deserves.

Behind the scenes of every medical update is the ongoing administrative burden that comes with complex care. As Paisley’s mom and full-time caregiver, I continue to spend countless hours navigating insurance denials, filing appeals, coordinating with multiple providers, and advocating for the coverage she needs.

While we remain focused on her health, the emotional and logistical toll of fighting for medical access is constant. It’s a role that requires persistence, organization, and endless energy.

Paisley’s case and our experience navigating a broken healthcare system, unfortunately, isn’t unique. That’s why it’s so important to advocate for continued research and spread awareness for eosinophilic disease. Every voice helps move us closer to change.

Editor’s Note:
APFED would like to hear from those who have had challenges with insurance coverage of an FDA-approved medication indicated to treat EoE. If you live in the U.S. and have been prescribed a medication to treat EoE, please answer a few questions to help us advocate for better coverage.

EoE Medication Coverage Survey

Share Your Story!

Tell us about the impact eosinophilic disorders have had on your life: apfed.org/share

 

APFED Celebrates First-Ever World EoE Day on May 22

FOR IMMEDIATE RELEASE

ATLANTA, GA — May 16 — The American Partnership for Eosinophilic Disorders (APFED) is proud to join the global launch of the “Unite for EoE: know the signs” campaign in observance of the first-ever World Eosinophilic Esophagitis (EoE) Day, taking place on May 22. This worldwide awareness initiative aims to educate the public about the symptoms of this chronic, allergic inflammatory disease of the esophagus.

EoE is often underdiagnosed or misdiagnosed, with many people enduring years of unresolved symptoms such as difficulty swallowing, food getting stuck, and persistent heartburn before receiving a diagnosis. If left untreated, EoE can lead to scarring and narrowing of the esophagus.

“EoE can greatly impact daily life, yet many people cope with symptoms for years without answers,” said Mary Jo Strobel, Executive Director of APFED. “This World EoE Day – the first ever – we’re encouraging people around the globe to spread awareness of EoE and talk to a doctor if they recognize symptoms of EoE in themselves or a loved one.”

As part of the campaign, APFED is disseminating a variety of resources, including:

  • A World EoE Day webpage featuring downloadable graphics, sample social media posts, and educational resources to empower individuals to raise awareness in their own communities
  • The “Could it be EoE?” tool to help individuals recognize common symptoms and guide conversations with healthcare providers
  • A Specialist Finder to connect patients with clinicians experienced in diagnosing and managing EoE

In addition, APFED will raise awareness through a World EoE Day social media campaign in collaboration with influencers to amplify the message and reach broader audiences.

To learn more and access the resources above, please visit apfed.org/eoeday.

APFED’s celebration of World EoE Day is supported by Abbott, Global Allergy & Airways Patient Platform, mBIOTA, Sanofi, Regeneron, and Takeda Pharmaceuticals America, Inc.​

About American Partnership for Eosinophilic Disorders (APFED)

Founded in 2001, the American Partnership for Eosinophilic Disorders (APFED) is a 501(c)(3) nonprofit organization that assists and supports patients and families affected by eosinophil-associated disorders, by providing education, creating awareness, supporting research, and promoting advocacy. To learn more, visit apfed.org.

###

Research Roundup, April 2025

This blog post is a research roundup of recent publications on eosinophilic diseases, including summaries, links, and citations for the following articles:

Long-Term Research Highlights Diagnostic Challenges and Treatment Outcomes for Patients Across the Netherlands

A multicenter retrospective study conducted in the Netherlands examined 70 patients with non-eosinophilic esophagitis eosinophilic gastrointestinal disorders (EGIDs) over nearly three decades. The research highlighted diagnostic challenges, noting that 61% of patients had normal endoscopy results despite symptoms like diarrhea and abdominal pain. Treatment responses varied, with eosinophilic colitis patients showing the most significant improvement, underscoring the need for standardized diagnostic criteria and more tailored treatment approaches. Learn more.

FDA Reviews GSK’s Depemokimab for Asthma and Nasal Polyps

​GSK’s depemokimab, an ultra-long-acting monoclonal antibody targeting interleukin-5 (IL-5), has been accepted for review by the U.S. Food and Drug Administration (FDA) for two indications: asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps (CRSwNP). If approved, it would be the first biologic therapy for these conditions requiring only twice-yearly dosing. The applications are supported by positive Phase III trial results from the SWIFT and ANCHOR studies, which demonstrated significant clinical benefits with a 26-week dosing interval. Read the press release.

Mepolizumab Efficacy and Safety in Patients with EGPA in Real Practice

A Spanish multicenter study involving patients with eosinophilic granulomatosis with polyangiitis (EGPA) found that long-term treatment with Nucala (mepolizumab) significantly reduced disease activity and allowed many patients to lower or discontinue glucocorticoid use. After six months, nearly half of the patients achieved clinical remission, and over 76% reduced their glucocorticoid dosage, with more than half stopping it entirely. The treatment was well-tolerated, with no severe adverse effects reported, suggesting that Nucala is an effective and safe option for managing EGPA in real-world settings. Learn more.

Segmental Overlap Is Common in Eosinophilic Gastrointestinal Diseases and Impacts Clinical Presentation and Treatment

​A new EGID Partners cohort overlap paper found that segmental overlap in EGIDs is common and significantly influences clinical presentation and treatment. The research revealed that patients with overlapping EGIDs often experience more severe symptoms and require more intensive therapies, such as systemic steroids and biologics. These findings underscore the importance of recognizing overlapping disease patterns to improve diagnosis and personalize treatment strategies. Read the journal summary and view a pdf of the paper and join the EGID Partners Registry here.

Vitamin D Deficiency an Independent Risk Factor in Eosinophilic CRSwNP

A recently published study indicates that vitamin D deficiency is an independent risk factor for eosinophilic chronic rhinosinusitis with nasal polyps (ECRSwNP). The research found that patients with ECRSwNP had significantly lower serum 25-hydroxyvitamin D levels compared to controls, and those with deficiency had over three times the risk of developing ECRSwNP. Combining vitamin D levels with peripheral eosinophil percentages may serve as a promising biomarker for identifying and managing this condition. Learn more.

Prognostic Value of I-SEE in Eosinophilic Esophagitis

A recent study explored the usefulness of the Index of Severity for Eosinophilic Esophagitis (I-SEE), a tool that measures the severity of eosinophilic esophagitis (EoE). Researchers found that patients with higher I-SEE scores, indicating more severe disease, were less likely to respond well to standard steroid treatments. This suggests that the I-SEE score can help doctors predict which patients might need more aggressive or alternative treatments for EoE. Learn more.

 

Celebrate National Volunteer Week with APFED

National Volunteer Week, observed from April 20-26, 2025, is a time to recognize and encourage the invaluable contributions of volunteers nationwide.  APFED volunteers play a crucial role in advancing our mission to improve the lives of those affected by eosinophil-associated diseases. This week is a great time to join our dedicated community and make a meaningful impact.​

5 Easy Ways to Get Involved with APFED:

  1. Become an APFED Volunteer: We periodically seek volunteers for short- and long-term projects in the areas of education, advocacy, and research. If you are willing and able to help, please complete our APFED Volunteer form to let us know more about you!
  2. Help Us Amplify the Patient’s Voice: Your story has the power to spark recognition and create understanding. Share your eosinophilic journey and help make these conditions more visible. Your perspective can help others as better understand eosinophilic disorders.
  3. Support Community Fundraising Events: Contribute to APFED’s mission by participating in or organizing community fundraising activities. Events like our upcoming Walk for HOPE not only raise essential funds to advance our mission, but also increase awareness about eosinophilic disorders.
  4. Engage in National Eosinophil Awareness Week (NEAW) and Global Awareness Days: Help raise awareness during NEAW, observed this year from May 18-24. During this week, we’ll also observe World Eosinophilic Diseases Day on May 18 and World EoE Day on May 22. Take a look at special lightings that will be hosted around the U.S. for APFED’s “Light Up for Eos Awareness” initiative.

The Impact of Your Involvement

This National Volunteer Week, we celebrate all who give their time to support APFED’s mission—you make a real difference, and our community appreciates you! If you’re looking to make a lasting impact, now is the perfect time to get involved. Your efforts can help advance vital research, raise awareness, and strengthen advocacy efforts for the eosinophil disease community.

 

Identifying Nutrition Gaps with Elimination Diets in EoE

by Kelli Miller, MS, RD, LD

In 2018, while working as a pediatric gastroenterology (GI) dietitian, I noticed my son Cole developing worsening reflux and vomiting around 6 to 9 months of age. At first, I thought it was just reflux, but my experience as a dietitian told me it was something more. After a hospital visit for dehydration, an endoscopy confirmed that Cole had EoE, and we decided to proceed with a 4-food elimination diet (milk, egg, wheat, soy). After 12 weeks of strict elimination, Cole’s endoscopy results were normalized.

The journey wasn’t easy. As an infant, Cole relied heavily on amino acid-based formula (AAF) due to his limited diet. Transitioning to AAF was tough due to its distinct taste, but he eventually adapted. We also faced significant financial strain since our insurance didn’t cover the cost of the formula, specialty foods, and medical expenses.

Today, Cole is thriving at 7 years old, still following his 4-food elimination diet (4-FED) with supplemental AAF to ensure he meets his nutritional needs.

Diet Therapies for EoE

  1. Elemental Diet (AAF) using AAF to replace all dietary antigens, has been a highly effective treatment for EoE. It can induce quick remission, with a 2020 study showing nearly 94% of patients achieving histologic remission. However, it can be challenging for older children or those with feeding disorders due to its restrictive nature. The diet can also be costly and emotionally taxing, especially for children who are socially impacted by food restrictions.
  2. Empiric Elimination Diet involves removing foods based on clinical experience. Based on the recent 2025 ACG guidelines for EoE, the efficiency ranges of various elimination diets are as follows: dairy-only elimination shows an efficacy of 35-45%, dairy and wheat elimination ranges from 40-45%, 4-FED has an efficacy of 40-50%, and a 6-food elimination diet (6-FED) ranges from 40-70%. The 6-FED removes milk, egg, wheat, soy, nuts, and seafood. While effective, these more restrictive diets come with risks like nutritional deficiencies and the need for repeat endoscopies. Additionally, the emotional toll of restricting food choices, can contribute to disordered eating patterns. Working closely with a dietitian is essential to navigate these challenges.

Identifying and Filling Nutrient Gaps

Key Nutrients in Elimination Diets

A 2019 study explored the major nutrients in the top allergens and protein was shown to be the top nutrient in milk, egg, soy, nuts and seafood. While other protein sources can be used, they may not always be well accepted, and feeding aversions or inflammation from flare-ups can make it difficult to consume adequate protein. Milk is particularly crucial as it is a major allergen in EoE and provides a complete protein with all essential amino acids, along with vital micronutrients like calcium, iron, and vitamin D. Without cow’s milk, many children struggle to meet these needs.

Plant-based milks (PBMs) are a common replacement, but they often lack the protein, fat, and vitamins found in cow’s milk. Soy and pea milks are exceptions but may not be suitable for children with other allergies. PBMs may also contain added sugars, so choosing unsweetened varieties is essential. A 2020 position paper states that when PBMs are used as the primary milk source for older children, their diet should also include alternative sources of protein, calcium, iron, and vitamins B-12 and D; thus, consulting with a dietitian is recommended. Additionally, it states that when cow’s milk is contraindicated, hypoallergenic formula is preferable.

Nutrition Considerations with Elimination Diets

Before beginning an elimination diet, it is essential for a dietitian to review the current diet. This helps assess potential risks of nutritional inadequacy, especially as the number of restricted foods increases. The dietitian will evaluate nutrition status, overall feeding behaviors and risks of deficiencies in essential nutrients like protein, calcium, and iron. As the diet changes, monitoring by a healthcare provider is important to prevent long-term issues, including the risk of feeding difficulties or texture aversions.

My Experience: Identifying and Filling Nutrient Gaps

After analyzing Cole’s diet on a 4-FED, I became aware that his intake of calories, fat, and essential vitamins like B-vitamins, calcium, and iron was insufficient. This was especially concerning as these nutrients are crucial for growth and development. Using supplemental AAF became an important strategy to fill these gaps. AAF provides a hypoallergenic nutrition source and has been shown to support children with food allergies and EoE by preventing nutritional deficiencies.

Final Thoughts

Managing EoE and elimination diets is challenging, both emotionally and nutritionally. Parents of children with EoE must balance restrictive diets with the nutritional needs of growing kids. From my experience with Cole, careful planning and regular monitoring are essential. Specialized nutritional supplements, like AAF, are often needed to ensure that nutritional gaps are filled.

The journey is not easy, but with support from healthcare professionals and dietitians, families can successfully manage EoE. With persistence and the right resources, families can successfully navigate the complexities of EoE and elimination diets.

Kelli Miller, MS, RD, LD has a Bachelor of Science degree in Food and Nutrition from Florida State University and Masters of Science in Health and Nutrition from the University of North Florida. She is a Registered Dietitian (RD) and a Board Certified Nutrition Support Clinician from 2012-2022. For more than twelve years, Kelli has worked in the clinical setting as an RD. She has specialized in pediatric nutrition for 9 of those years, specifically GI/Allergy, Critical Care, and Oncology. During her 6 years as a GI dietitian, she grew the nutrition clinics for Feeding Difficulties, IBD, Carbohydrate Malabsorption, Liver Transplant, Eosinophilic Gastrointestinal Disorders, and General GI. Kelli is currently employed by Ajinomoto Cambrooke as a Clinical Specialist focusing on gastrointestinal and allergy nutrition. She is also mom to a 7-year-old boy with Eosinophilic Esophagitis and strives to find ways to improve outcomes in children with GI and allergic medical conditions.